快樂小藥師
- Nov 28 Mon 2011 05:40
[US pharmacist]Allergic Rhinitis: Nonprescription Treatment Options 過敏性鼻炎:非處方的治療選擇
- Nov 27 Sun 2011 04:20
[WebMD]清潔牙齒有益於心臟健康
- Nov 26 Sat 2011 04:42
學語言真的靠天份!科學家發現「語言基因」
「學習語言」對某些人而言很簡單,但對另一些人卻是惡夢一場。語言天才可能會開玩笑的說:「認命吧,這種事是要靠天分滴!」不幸的是,這句話恐怕說對了。位於德國萊比錫的馬克斯普朗克研究所(MPI)發現,有種稱為「FOXP2」的遺傳基因很可能是學習語言的關鍵所在!
- Nov 25 Fri 2011 10:44
[WebMD]維生素D能影響免疫反應
- Nov 24 Thu 2011 10:43
[WebMD]何時是最好的運動時間?
- Nov 23 Wed 2011 10:39
[WebMD]使用Ecallantide治療急性HAE後無復發
研究者在美國過敏、氣喘與免疫學院2011年科學會議中報告指出,急性遺傳性血管水腫(HAE)病患使用ecallantide治療可以獲得持久的反應,只有少數病患復發,僅1名病患出現反彈性發作。
- Nov 22 Tue 2011 05:51
[WebMD][Ask the Nutritionist]What Vitamin and Mineral Supplements Can and Can’t Do
- Nov 21 Mon 2011 10:50
[藥物介紹]Vilazodone (Viibryd, Forest Pharmaceuticals)
Indication and Clinical Profile
Vilazodone is the newest selective serotonin reuptake inhibitor (SSRI) approved for the treatment of major depressive disorder (MDD). MDD, affecting nearly 19 million people in the U.S., is characterized by depressed mood, loss of interest in usual activities, significant change in weight or appetite, sleep disorders, increased fatigue, impaired concentration, and suicidal thoughts or behavior. The most commonly prescribed drugs for MDD are SSRIs and serotonin-norepinephrine reuptake inhibitors (SNRIs). These agents are preferred because of their relative efficacy and safety and because they are less toxic in overdose than older antidepressants (i.e., tricyclics and monoamine oxidase inhibitors [MAOIs]).
- Nov 20 Sun 2011 10:36
[藥物介紹]Spinosad (Natroba, ParaPRO)
Indication and Clinical Profile
Spinosad topical suspension 0.9% is approved for the treatment of head lice infestation in patients aged ≥4 years. Head lice, a common problem among U.S. schoolchildren, are spread mainly by direct head-to-head contact with someone who already has head lice. Spinosad provides an alternative to OTC shampoos containing pyrethrin or permethrin and prescription medications including malathion, lindane, and benzyl alcohol lotion.
- Nov 19 Sat 2011 10:30
[藥物介紹]Lurasidone (Latuda, Sunovion Pharmaceuticals)
Indication and Clinical Profile5,6
Lurasidone is the newest atypical antipsychotic (AA) agent approved for the treatment of schizophrenia in adults. Annually, schizophrenia affects about 1% of the U.S. population aged ≥18 years. The disorder is characterized by three symptom types: positive (abnormal behavior), negative (inability to perform daily activities), and cognitive (inability to make decisions).
- Nov 18 Fri 2011 10:17
[藥物介紹]Dabigatran (Pradaxa, Boehringer Ingelheim Pharmaceuticals)
Dabigatran (Pradaxa, Boehringer Ingelheim Pharmaceuticals)
Indication and Clinical Profile3,4
Dabigatran was approved by the FDA to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). It is the first alternative to warfarin to be approved by the FDA. Replacement drugs for warfarin are considered potential blockbusters because of the critical need for them, particularly as the aging population becomes more vulnerable to AF and other conditions that can cause blood clots. AF affects more than 2 million Americans.
- Nov 17 Thu 2011 10:09
[藥物介紹]Azilsartan (Edarbi, Takeda Pharmaceuticals America)
Indication and Clinical Profile1,2
Azilsartan is the newest angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension, alone or in combination with other antihypertensive agents. Hypertension, defined as systolic/diastolic blood pressure (BP) of ≥140 mmHg/90 mmHg, affects approximately 75 million Americans and is associated with increased risk of stroke, heart failure, heart attack, renal failure (RF), and death. Drugs that block the renin-angiotensin system, including ARBs, ACE inhibitors, and renin inhibitors, have become standard treatments for hypertension.
- Nov 16 Wed 2011 03:00
[Medscape][Medscape Medical News]Oral Microbial Profiles Differ With Varying Pneumonia Risk
The mix of oral bacteria differs in individuals with different risks for pneumonia, Samit Joshi, DO, MPH, a fellow in infectious diseases at the Yale School of Medicine in New Haven, Connecticut, reported here at the Infectious Diseases Society of America (IDSA) 49th Annual Meeting.
- Nov 15 Tue 2011 04:46
BB cream (BB霜)顯微實驗
BB 霜,正確的說,應該是遮瑕霜
BB就是Blemish Balm,也就是遮瑕,以往都是使用遮瑕膏,但是隨著民眾對美妝的要求無限上綱,所以廠商就推出了BB 霜或是BB乳液,直接讓你抹整臉。
- Nov 14 Mon 2011 04:41
[NEJM][ORIGINAL ARTICLE]Glucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis
Severe acute alcoholic hepatitis is a life-threatening alcoholic liver disease.1 Although glucocorticoid treatment is recommended2,3 and improves survival,4-11 mortality remains high, with 35% of patients dying within 6 months.1Long-term alcohol consumption increases intestinal permeability, worsens endotoxemia,12 stimulates Kupffer cells,13 and thus increases production of proinflammatory cytokines.14 High levels of tumor necrosis factor α (TNF-α) activate cell-death pathways and induce the production of reactive oxygen species, notably superoxide anions, by the hepatocyte mitochondria, leading to cell death.
- Nov 13 Sun 2011 04:39
logitech wireless touchpad 羅技無線觸控板試用
- Nov 12 Sat 2011 06:08
[WebMD]超音波導引神經阻斷減緩腿部骨折疼痛
研究人員在美國小兒科學會2011年國際研討會中報告指出,對於因為股骨骨折而疼痛的孩童,超音波導引神經阻斷可顯著改善疼痛控制而可減少副作用和減輕護士的負擔。
- Nov 11 Fri 2011 01:06
[WebMD]為什麼指甲刮黑板的聲音讓你苦腦?
- Nov 10 Thu 2011 06:46
dulcofibre溶解實驗
Dulcofibre,簡單的說,就是水解纖維,主要是葡甘露聚醣,用來增加飽足感
- Nov 09 Wed 2011 11:58
[Medscape][Medscape Education Oncology]What Pharmacists Should Know About Stem Cell Transplantation
藥師應該對幹細胞移植知道什麼呢?
- Nov 08 Tue 2011 09:21
[WebMD]長時間少量飲酒也會增加乳癌風險
- Nov 07 Mon 2011 06:06
[WebMD]瑜伽、伸展運動可舒緩下背痛
- Nov 07 Mon 2011 05:02
[WebMD]肥胖會影響流感疫苗的反應
根據線上國際肥胖期刊(International Journal of Obesity)上的一篇研究結論,隨著流感季節開始,北卡羅來納大學教堂山分校的研究者首次提出,流感疫苗對肥胖者的保護力可能小於健康體重者。
- Nov 06 Sun 2011 04:59
[WebMD]如何讓男性停止打呼
- Nov 05 Sat 2011 05:58
[WebMD]晚上服用血壓藥物效果更好
根據新研究指出,罹患慢性腎臟病(CKD)和高血壓的病患,睡前服用至少一種降血壓藥物,可顯著改善血壓控制,且與降低心血管事件風險有關。